Analyst firms · Oppenheimer · ANTX

Oppenheimer ANTX price target and rating history

AN2 Therapeutics Inc. (ANTX) · Health Care

Oppenheimer rates AN2 Therapeutics Inc. (ANTX) Perform with a $22 price target, as of its latest action on Feb 12, 2024. It has published 3 rating actions on ANTX since April 2022, including 0 upgrades and 1 downgrade.

Current rating
Perform
Price target
$22
Median target, all firms
Too few
Actions on ANTX
3

Oppenheimer price target on ANTX

$24$22$202023202420252026
Oppenheimer price target on ANTX, each point a stated target, April 2022 to July 2022.

Every Oppenheimer rating on ANTX

Questions about Oppenheimer and ANTX

What is Oppenheimer's price target for ANTX?
Oppenheimer's latest stated price target for AN2 Therapeutics Inc. (ANTX) is $22, from its action on Jul 18, 2022.
What is Oppenheimer's rating on ANTX?
Oppenheimer rates ANTX Perform, a neutral rating, as of Feb 12, 2024.
When did Oppenheimer last change its view on ANTX?
On Feb 12, 2024, Oppenheimer downgrades to Perform from Outperform.

More ANTX rating histories

All Oppenheimer ratingsANTX news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.